Reaction Biology, 4HF Biotec offer new cell-based services
October 19, 2020 -- Reaction Biology and 4HF Biotec announced that they are offering a new cell-based service that will give customers a comprehensive understanding of their candidates. The service will combine Reaction's ProLiFiler cell assay service with 4HF's Biomarker Analysis and Mode of Action (MoA) Finder tools
CHMP recommends Alnylam's RNAi therapeutic for approval
October 16, 2020 -- The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) posted a positive opinion recommending approval for Alnylam Pharmaceutical's lumasiran, an investigational RNA interference (RNAi) therapeutic for the treatment of primary hyperoxaluria type 1.
Atum licenses cell line development tools to Rentschler Biopharma
October 14, 2020 -- Rentschler Biopharma has signed a full contract development and manufacturing organization license agreement for Atum's leap-in transposase platform.
ERS Genomics licenses gene editing tech to FASMAC
October 14, 2020 -- ERS Genomics, which has access to foundational CRISPR/Cas9 intellectual property co-owned by Emmanuelle Charpentier, has signed an agreement with FASMAC of Japan.
Ionis' inhaled antisense drug shows promise as CF treatment
October 13, 2020 -- Ionis Pharmaceuticals has released positive data from a clinical trial evaluating IONIS-ENAC-2.5Rx, an investigational antisense medicine designed to reduce expression of epithelial sodium channel in cystic fibrosis (CF) patients.
Oncopeptides moves to file for regulatory approvals
October 12, 2020 -- Oncopeptides plans to submit an application for a conditional marketing authorization of melflufen in the European Union, based on the phase II Horizon study in relapsed refractory multiple myeloma.
Allele Biotech supports COVID-19 vaccine manufacturing
October 2, 2020 -- Allele Biotechnology and Pharmaceuticals' current good manufacturing practices-grade induced pluripotent stem cells are being used as packaging factories for a dual COVID-19 vaccine.
10 ways to promote antiracism in research environments
October 1, 2020 -- A pair of laboratory scientists has proposed 10 ways principal investigators and group leaders can cultivate antiracist research environments.
Qualigen expands partnership with UofL for cancer drug
October 1, 2020 -- Qualigen Therapeutics has extended its research agreement with the University of Louisville (UofL) to advance development of Qualigen's anticancer drug candidate.
Ionis, Genuity Science partner to advance RNA-targeted therapies
October 1, 2020 -- Ionis Pharmaceuticals and Genuity Science have entered a multiyear collaboration to accelerate the discovery and development of genetically validated targets for up to 20 diseases.
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter